Management & Team
Mrs. Antholz, a German Attorney-at-Law, is the Managing Director of Mannin GmbH. In her role, she is responsible for Mannin’s German operations as well as EU market.
Prior to her role at Mannin GmbH, Isabel was the lead of Deloitte Germany’s service line for Global Investment & Innovation Incentives. Isabel advised clients (including Mannin) in all areas of tax and R&D incentive funding, which is a key revenue source for Mannin.
Dr. Peter Sennhenn
Lead Medicinal Chemistry
Dr. Peter Sennhenn is the Lead Medicinal Chemist at Mannin GmbH and holds a Ph.D. in organic chemistry from the University of Heidelberg, Germany.
Peter is an experienced medicinal chemist and drug hunter adding 25 years of drug discovery experience from leading positions in big pharma and biotech industry world wide. He has a proven track record of processing small molecules from hit to lead to the clinic within different target families and therapeutic areas.
Fanny Schoemann is the Office Manager for Mannin GmbH. In this role she is responsible for the day to day operational tasks including preparation of the monthly accounting, organisiation of meetings with business partners and the team in Canada, as well as assisting the Managing Director and Lead Medicinal Chemist with a variety of tasks.
Prior to working for Mannin GmbH, Fanny has worked for 18 years in various banks in Germany, the UK and Singapore, before joining a small start-up company in Leipzig.
Dr. Robin Schoemaker
Dr. Robin Schoemaker studied chemistry at the University of Oldenburg and finished his master studies and PhD at the Technische Universität Dresden, with focus on synthetic chemistry. With his expertise in phosphorus chemistry and handling highly reactive compounds he contributes to Mannin’s success by designing synthetic ways towards target molecules and supporting the team with regards to questions of laboratory safety.
Robin’s tasks as Chemistry Scientist at our laboratory include the development of synthetic routes for bioactive small molecules and the execution of organic chemical transformations.
Dr. Stefan Saretz
Dr. Stefan Saretz is a Chemistry Scientist at Mannin and holds a PhD in inorganic chemistry from the University of Leipzig.
After completing his doctorate in the field of oncology, Stefan first turned to antibacterial and antiviral research and then joined the groups of Mirko Buchholz at the Fraunhofer Institute for Cell Therapy and Immunology and Mark Brönstrup at the Helmholtz Centre for Infection Research in the areas of hit to lead and lead optimization. He is now bringing his broad experience to Mannin,to develop synthesis pathways for bioactive small molecules.
Dr. Andreas Schoop
Dr. Andreas Schoop holds a PhD in Organic Chemistry from the University of Münster and was a postdoctoral fellow at Stanford University. He has contributed to bringing several compounds to the clinic in various positions in the pharmaceutical and biotech industry and has over 25 years of experience as a scientist and manager in medicinal chemistry and drug discovery. He is co-author of several patent applications and publications and has valuable experience in the field of structure-based drug discovery.
At Mannin, Dr. Schoop is Head of Medicinal Chemistry in Leipzig and is responsible for the implementation of strategies in the various projects.
Moritz Marek is an intern in the field of medicinal chemistry. After completing his studies at the Technical University of Dresden, he received his Master's degree in chemistry.
There Moritz performed research in the fields of organometallic chemistry (Prof. Knölker) and chemo-enzymatic synthesis (Prof. Gulder).
During his 6-month internship with us, he will support the team in the lab and thus gain further experience in the field of medicinal chemistry. Afterwards, he will start his doctoral studies at the TU Dresden.